Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/7/2025

Antibiotic Resistance and Treatment Guidelines

Introduction to Antibiotic Resistance

  • Approximately 25-50% of S. pneumoniae strains in the US demonstrate relative or high resistance to penicillin, according to the American Academy of Allergy, Asthma, and Immunology 1
  • Resistance levels are defined by the National Committee for Clinical Laboratory Standards, with susceptible strains having an MIC ≤0.06 mg/mL, intermediate resistance having an MIC of 0.1-1.0 mg/mL, and resistant strains having an MIC ≥2.0 mg/mL, as per the Clinical Infectious Diseases guidelines 2

Bacterial Resistance Patterns

  • Approximately 50% of Haemophilus influenzae strains are β-lactamase producing, as reported by the American Academy of Allergy, Asthma, and Immunology 1
  • 90-100% of Moraxella catarrhalis strains are β-lactamase producing, according to the American Academy of Allergy, Asthma, and Immunology 1
  • 100% of Streptococcus pyogenes remain susceptible to penicillin despite increasing macrolide resistance, as per the Clinical Infectious Diseases guidelines 3

Treatment Guidelines for Respiratory Infections

  • For pneumonia, intermediate resistance to penicillin is not clinically important, but high-grade resistance (MIC >4 mg/mL) may be significant, as reported by the Clinical Infectious Diseases guidelines 2
  • High-dose amoxicillin (90 mg/kg/day in 2 divided doses) can overcome resistance in most cases, according to the American Academy of Allergy, Asthma, and Immunology 1
  • For severe infections with suspected drug-resistant S. pneumoniae, alternative agents such as respiratory fluoroquinolones may be needed, as per the Clinical Infectious Diseases guidelines 4

Treatment Guidelines for Skin and Soft Tissue Infections

  • For community-acquired skin infections, empiric therapy should account for potential MRSA, which has high prevalence in many communities, as reported by the Clinical Infectious Diseases guidelines 3
  • For serious infections, assume resistance and use agents effective against MRSA (vancomycin, linezolid, or daptomycin), according to the Clinical Infectious Diseases guidelines 3

Risk Factors for Antibiotic Resistance

  • Age ≥65 years (OR 3.8), alcoholism (OR 5.2), β-lactam therapy within previous 3 months (OR 2.8), multiple medical comorbidities, exposure to children in daycare centers, and immunosuppressive illness are risk factors for antibiotic resistance, as reported by the American Journal of Respiratory and Critical Care Medicine 5

General Treatment Principles

  • Regional resistance patterns vary significantly across the United States, as reported by the Clinical Infectious Diseases guidelines 6
  • Unnecessary broad-spectrum antibiotic use contributes to increasing resistance, although the reference for this statement is to be ignored
  • When possible, obtain appropriate cultures before initiating antibiotics and de-escalate therapy based on susceptibility results, as per the Clinical Infectious Diseases guidelines 3